- Home
- GALT vs FLXS Comparison
GALT vs FLXS Comparison
Compare GALT & FLXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GALT | FLXS |
|---|---|---|
| Founded | 2000 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Home Furnishings |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 297.0M | 290.6M |
| IPO Year | 2008 | 1995 |
Fundamental Metrics
Financial Performance| Metric | GALT | FLXS |
|---|---|---|
| Price | $3.45 | $76.19 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $8.50 | ★ $54.00 |
| AVG Volume (30 Days) | ★ 528.1K | 36.9K |
| Earning Date | 05-15-2026 | 04-20-2026 |
| Dividend Yield | N/A | ★ 1.41% |
| EPS Growth | ★ 36.84 | N/A |
| EPS | N/A | ★ 3.63 |
| Revenue | N/A | ★ $441,073,000.00 |
| Revenue This Year | N/A | $4.51 |
| Revenue Next Year | N/A | $4.89 |
| P/E Ratio | ★ N/A | $21.18 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.03 | $33.11 |
| 52 Week High | $7.13 | $79.70 |
Technical Indicators
Market Signals| Indicator | GALT | FLXS |
|---|---|---|
| Relative Strength Index (RSI) | 43.95 | 63.42 |
| Support Level | $2.75 | $72.11 |
| Resistance Level | $3.35 | $77.19 |
| Average True Range (ATR) | 0.32 | 2.80 |
| MACD | -0.11 | -0.19 |
| Stochastic Oscillator | 28.78 | 66.15 |
Price Performance
Historical ComparisonAbout GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
About FLXS Flexsteel Industries Inc.
Flexsteel Industries Inc is a United States-based company that manufactures, imports, and markets residential upholstered wooden furniture products. Its product offerings include sofas, loveseats, chairs, rockers, desks, tables, convertible bedding units, and bedroom furniture. The company's products are intended for use in home, office, hotel, healthcare, and other contract applications. A featured component in the company's upholstered furniture is the durable Blue Steel Spring. It operates in the business segment of Furniture products. The company's furniture products business involves the distribution of manufactured and imported products for residential markets.